TOR signalling in bugs, brain and brawn

Nature Reviews Molecular Cell Biology

Volumn 4, Issue 2, 2003, Pages 117-126

  Jacinto, Estela ^a   Hall, Michael N ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PHOSPHATASE; PROTEIN KINASE; RAPAMYCIN; REGULATOR PROTEIN; TACROLIMUS; TARGET OF RAPAMYCIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; DRUG TARGETING; ENZYME INHIBITION; FLY; FUNGUS GROWTH; GENETIC CONSERVATION; INSECT; MAMMAL CELL; MUSCLE CELL; NERVE CELL GROWTH; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; YEAST;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; HUMANS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTOR PROTEIN-TYROSINE KINASES; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; TACROLIMUS BINDING PROTEIN 1A;

ANIMALIA; FUNGI; INSECTA; MAMMALIA;

EID: 0037312507     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1018     Document Type: Review

References (117)

1. Waite, K. A. & Eng, C. Protean PTEN: form and function. Am. J. Hum. Genet. 70, 829-844 (2002).
2. Hengstschlager, M. Tuberous sclerosis complex genes: from flies to human genetics. Arch. Dermatol. Res. 293, 383-386 (2001).
3. Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355-365 (2001).
4. Conlon, I. & Raff, M. Size control in animal development. Cell 96, 235-244 (1999). An insightful review on the whys and hows of size control. This review discusses how cell size and number determine animal size.
5. Schmelzle, T. & Hall, M. N. TOR, a central controller of cell growth. Cell 103, 253-262 (2000). A comprehensive review on how the TOR signalling pathway in both yeast and mammals controls cell growth.
6. Heitman, J., Mowa, N. R. & Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905-909 (1991).
7. Kunz, J. et al. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73, 585-596 (1993).
8. Helliwell, S. B. et al. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol. Biol. Cell 5, 105-118 (1994).
9. Weisman, R. & Choder, M. The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine. J. Biol. Chem. 276, 7027-7032 (2001).
10. Cruz, M. C. et al. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans. Mol. Cell. Biol. 19, 4101-4112 (1999),
11. Menand, B. et al. Expression and disruption of the Arabidopsis TOR (target of rapamycin) gene. Proc. Natl Acad. Sci. USA 99, 6422-6427 (2002).
12. Long, X. et al. TOR deficiency in C. elegans causes developmental arrest and intestinal atrophy by inhibition of mRNA translation. Curr. Biol. 12, 1448 (2002).
13. Oldham, S., Montagne, J., Radimerski, T., Thomas, G. & Hafen, E. Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 14, 2689-2694 (2000).
14. Zhang, H., Stallock, J. P., Ng, J. C., Reinhard, C. & Neufeld, T. P. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14, 2712-2724 (2000).
15. Brown, E. J. et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756-758 (1994).
16. Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S. H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 76, 35-43 (1994).
17. Chiu, M. I., Katz, H. & Berlin, V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc. Natl Acad. Sci. USA 91, 12574-12578 (1994).
18. Keith, C. T. & Schreiber, S. L. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270, 50-51 (1995).
19. Brunn, G. J. et al. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 277, 99-101 (1997).
20. Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H. & Sabatini, D. M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl Acad. Sci. USA 95, 1432-1437 (1998).
21. Isotani, S. et al. Immunopurified mammalian target of rapamycin phosphorylates and activates p70 S6 kinase α in vitro. J. Biol. Chem. 274, 34493-34498 (1999).
22. Andrade, M. A. & Bork, P. HEAT repeats in the Huntington's disease protein. Nature Genet. 11, 115-116 (1995).
23. Bosotti, R., Isacchi, A. & Sonnhammer, E. L. FAT: a novel domain in PIK-related kinases. Trends Biochem. Sci. 25, 225-227 (2000).
24. Loewith, R. et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457-468 (2002). This paper describes two structurally and functionally distinct TOR complexes in yeast (TORC1 and TORC2), and provides the molecular basis for the signalling specificity of TOR. It shows that TORC1 and possibly TORC2 are conserved.
25. Roberg, K. J., Bickel, S., Rowley, N. & Kaiser, C. A. Control of amino acid permease sorting in the late secretory pathway of Saccharomyces cerevisiae by SEC13, LST4, LST7 and LST8. Genetics 147, 1569-1584 (1997).
26. Liu, Z., Sekito, T., Epstein, C. B. & Butow, R. A. RTG-dependent mitochondria to nucleus signaling is negatively regulated by the seven WD-repeat protein Lst8p. EMBO J. 20, 7209-7219 (2001).
27. Hara, K. et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189 (2002).
28. Kim, D. H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175 (2002). References 27 and 28 provide evidence that raptor is required for mTOR regulation of 4E-BP and S6K. Some discrepancies on the nutrient and rapamycin sensitivity of the mTOR/raptor complex and the role of raptor on mTOR kinase activity might stem from different experimental conditions.
29. Gao, X. et al. Tsc tumour suppressor proteins antagonize amino-acid - TOR signalling. Nature Cell Biol. 4, 699-704 (2002).
30. Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biol. 4, 648-657 (2002).
31. Potter, C. J., Pedraza, L. G. & Xu, T. Akt regulates growth by directly phosphorylating Tsc2. Nature Cell Biol. 4, 658-665 (2002). References 29-31 and 57 provide complementary evidence on how the TSC complex is negatively regulated by Akt, and how the TSCs negatively regulate TOR.
32. Barbet, N. C. et al. TOR controls translation initiation and early G1 progression in yeast. Mol. Biol. Cell 7, 25-42 (1996). The first paper to propose TOR as a controller of cell growth, and the first paper to present evidence that TOR responds to nutrients.
33. Schmidt, A., Kunz, J. & Hall, M. N. TOR2 is required for organization of the actin cytoskeleton in yeast. Proc. Natl Acad. Sci. USA 93, 13780-13785 (1996).
34. Cardenas, M. E., Cutler, N. S., Lorenz, M. C., Di Como, C. J. & Heitman, J. The TOR signaling cascade regulates gene expression in response to nutrients. Genes Dev. 13, 3271-3279 (1999).
35. Hardwick, J. S., Kuruvilla, F. G., Tong, J. K., Shamji, A. F. & Schreiber, S. L. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc. Natl Acad. Sci. USA 96, 14866-14870 (1999). References 34, 35 and 45 provide compelling evidence on the negative regulatory role of TOR in transcription of nutrient-responsive genes.
36. Powers, T. & Walter, P. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae. Mol. Biol. Cell 10, 987-1000 (1999).
37. Zaragoza, D., Ghavidel, A., Heitman, J. & Schultz, M. C. Rapamycin induces the GO program of transcriptional repression in yeast by interfering with the TOR signaling pathway. Mol. Cell. Biol. 18, 4463-4470 (1998).
38. Kamada, Y. et al. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J. Cell Biol. 150, 1507-1513 (2000).
39. Noda, T. & Ohsumi, Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273, 3963-3966 (1998).
40. Schmidt, A., Beck, T., Koller, A., Kunz, J. & Hall, M. N. The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease. EMBO J. 17, 6924-6931 (1998).
41. Beck, T., Schmidt, A. & Hall, M. N. Starvation induces vacuolar targeting and degradation of the tryptophan permease in yeast. J. Cell Biol. 146, 1227-1238 (1999)
42. Blommaart, E. F., Luiken, J. J., Blommaart, P. J., van Woerkom, G. M. & Meijer, A. J. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270, 2320-2326 (1995).
43. Shigemitsu, K. et al. Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells. J. Biol. Chem. 274, 1058-1065 (1999).
44. Edinger, A. L. & Thompson, C. B. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13, 2276-2288 (2002).
45. Beck, T. & Hall, M. N. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors. Nature 402, 689-692 (1999).
46. Komeili, A., Wedaman, K. P., O'Shea, E. K. & Powers, T. Mechanism of metabolic control. Target of rapamycin signaling links nitrogen quality to the activity of the rtg1 and rtg3 transcription factors. J. Cell Biol. 151, 863-878 (2000).
47. Crespo, J. L., Powers, T., Fowler, B. & Hall, M. N. The TOR-controlled transcription activators GLN3, RTG1, and RTG3 are regulated in response to intracellular levels of glutamine. Proc. Natl Acad. Sci. USA 99, 6784-6789 (2002).
48. Shamji, A. F., Kuruvilla, F. G. & Schreiber, S. L. Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins. Curr. Biol. 10, 1574-1581 (2000).
49. Dilova, I., Chen, C. Y. & Powers, T. Mks1 in concert with tor signaling negatively regulates RTG target gene expression in S. cerevisiae. Curr. Biol. 389-395 (2002).
50. Sekito, T., Liu, Z., Thornton, J. & Butow, R. A. RTG-dependent mitochondria-to-nucleus signaling is regulated by MKS1 and is linked to formation of yeast prion [URE3]. Mol. Biol. Cell 13, 795-804 (2002).
51. Neshat, M. S. et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl Acad. Sci. USA 98, 10314-10319 (2001).
52. Podsypanina, K. et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice. Proc. Natl Acad. Sci. USA 98, 10320-10325 (2001).
53. Gingras, A. C., Raught, B. & Sonenberg, N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15, 807-826 (2001). An excellent review on mTOR signalling.
54. Gingras, A. C. et al. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15, 2852-2864 (2001).
55. Alessi, D. R., Kozlowski, M. T., Weng, Q. P., Morrice, N. & Avruch, J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8, 69-81 (1998).
56. Pullen, N. et al. Phosphorylation and activation of p70s6k by PDK1. Science 279, 707-710 (1998).
57. Tee, A. R. et al. Tuberous sclerosis complex-1 and-2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl Acad. Sci. USA 99, 13571-13576 (2002).
58. Nave, B. T., Ouwens, M., Withers, D. J., Alessi, D. R. & Shepherd, P. R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344, 427-431 (1999)
59. Sekulic, A. et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60, 3504-3513 (2000).
60. Dennis, P. B. et al. Mammalian TOR: a homeostatic ATP sensor. Science 294, 1102-1105 (2001).
61. Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. & Chen, J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294, 1942-1945 (2001).
62. Jaeschke, A. et al. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159, 217-224 (2002).
63. Hara, K. et al. Amino acid sufficiency and mTOR regulate p70 S6 kinase and elF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273, 14484-14494 (1998). The first of several papers to suggest that mTOR responds to nutrients, amino acids in particular (see also references 64-66).
64. Wang, X., Campbell, L. E., Miller, C. M. & Proud, C. G. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 334, 261-267 (1998).
65. Xu, G. et al. Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic β-cells. A possible role in protein translation and mitogenic signaling. J. Biol. Chem. 273, 28178-28184 (1998).
66. Anthony, J. C. et al. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J. Nutr. 130, 2413-2419 (2000).
67. Abraham, R. T. Identification of TOR signaling complexes: more TORC for the cell growth engine. Cell 111, 9-12 (2002).
68. McDaniel, M. L., Marshall, C. A., Pappan, K. L. & Kwon, G. Metabolic and autocrine regulation of the mammalian target of rapamycin by pancreatic β-cells. Diabetes 51, 2877-2885 (2002). An interesting review on mTOR in β-cells, mTOR might control overall body growth in addition to autonomous cell growth.
69. Goldberg, Y. Protein phosphatase 2A: who shall regulate the regulator? Biochem. Pharmacol. 57, 321-328 (1999).
70. Luke, M. M. et al. The SAP, a new family of proteins, associate and function positively with the SIT4 phosphatase. Mol. Cell. Biol. 16, 2744-2755 (1996).
71. Sutton, A., Immanuel, D. & Arndt, K. T. The SIT4 protein phosphatase functions in late G1 for progression into S phase. Mol. Cell. Biol. 11, 2133-2148 (1991).
72. Di Como, C. J. & Arndt, K. T. Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev. 10, 1904-1916 (1996). A thorough study that shows how phosphatase association with regulatory subunits is controlled by nutrients and TOR.
73. Jiang, Y. & Broach, J. R. Tor proteins and protein phosphatase 2A reciprocally regulate Tap42 in controlling cell growth in yeast. EMBO J. 18, 2782-2792 (1999).
74. Jacinto, E., Guo, B., Arndt, K. T., Schmelzle, T. & Hall, M. N. TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol. Cell 8, 1017-1026 (2001).
75. Peterson, R. T., Desai, B. N., Hardwick, J. S. & Schreiber, S. L. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycin associated protein. Proc. Natl Acad. Sci. USA 96, 4438-4442 (1999).
76. Murata, K., Wu, J. & Brautigan, D. L. B cell receptor-associated protein α4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc. Natl Acad. Sci. USA 94, 10624-10629 (1997).
77. Inui, S. et al. Ig receptor binding protein 1 (α4) is associated with a rapamycin-sensitive signal transduction in lymphocytes through direct binding to the catalytic subunit of protein phosphatase 2A. Blood 92, 539-546 (1998).
78. Trockenbacher, A. et al. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nature Genet. 29, 287-294 (2001).
79. Liu, J., Prickett, T. D., Elliott, E., Meroni, G. & Brautigan, D. L. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4. Proc. Natl Acad. Sci. USA 98, 6650-6655 (2001).
80. Chung, H., Nairn, A. C., Murata, K. & Brautigan, D. L. Mutation of Tyr307 and Leu309 in the protein phosphatase 2A catalytic subunit favors association with the α4 subunit which promotes dephosphorylation of elongation factor-2. Biochemistry 38, 10371-10376 (1999).
81. Saucedo, L. & Edgar, B. Why size matters: altering cell size. Curr. Opin. Genet. Dev. 12, 565-571 (2002).
82. Bohni, R. et al. Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97, 865-875 (1999).
83. Leevers, S. J., Weinkove, D., MacDougall, L. K., Hafen, E. & Waterfield, M. D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15, 6584-6594 (1996). The first in a series of excellent papers on cell growth in Drosophila.
84. Rintelen, F., Stocker, H., Thomas, G. & Hafen, E. PDK1 regulates growth through Akt and S6K in Drosophila. Proc. Natl Acad. Sci. USA 98, 15020-15025 (2001).
85. Verdu, J., Buratovich, M. A., Wilder, E. L. & Birnbaum, M. J. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB. Nature Cell Biol. 1, 500-506 (1999).
86. Montagne, J. et al. Drosophila S6 kinase: a regulator of cell size. Science 285, 2126-2129 (1999).
87. Goberdhan, D. C., Paricio, N., Goodman, E. C., Mlodzik, M. & Wilson, C. Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev. 13, 3244-3258 (1999).
88. Potter, C. J., Huang, H. & Xu, T. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell 105, 357-368 (2001).
89. Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E. & Hariharan, I. K. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105, 345-355 (2001).
90. Miron, M. et al. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nature Cell Biol. 3, 596-601 (2001).
91. Rommel, C. et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biol. 3, 1009-1013 (2001).
92. Bodine, S. C. et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biol. 3, 1014-1019 (2001). References 91 and 92 argue for a major role of the mTOR and Akt pathways in controlling overload-induced skeletal muscle hypertrophy.
93. Musaro, A., McCullagh, K. J., Naya, F. J., Olson, E. N. & Rosenthal, N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400, 581-585 (1999).
94. 2+-dependent calcineurin signalling pathway. Nature 400, 576-581 (1999).
95. Pallafacchina, G., Calabria, E., Serrano, A. L., Kalhovde, J. M. & Schiaffino, S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc. Natl Acad. Sci. USA 99, 9213-9218 (2002).
96. Reynolds, T. H., Bodine, S. C. & Lawrence, J. C. Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J. Biol. Chem. 277, 17657-17662 (2002).
97. Baar, K. & Esser, K. Phosphorylation of p70(S6k) correlates with increased skeletal muscle mass following resistance exercise. Am. J. Physiol. 276, C120-C127 (1999).
98. Shioi, T. et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22, 2799-2809 (2002).
99. Martin, K. C. et al. Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: a function for local protein synthesis in memory storage. Cell 91, 927-938 (1997).
100. Casadio, A. et al. A transient, neuron-wide form of CREB-mediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell 99, 221-237 (1999).
101. Tang, S. J. et al. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl Acad. Sci. USA 99, 467-472 (2002). References 100 and 101 show that TOR is involved in LTF and LTP.
102. Takei, N., Kawamura, M., Hara, K., Yonezawa, K. & Nawa, H. Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes: comparison with the effects of insulin. J. Biol. Chem. 276, 42818-42825 (2001).
103. Khan, A., Pepio, A. M. & Sossin, W. S. Serotonin activates S6 kinase in a rapamycin-sensitive manner in Aplysia synaptosomes. J. Neurosci. 21, 382-391 (2001).
104. Raymond, C. R., Redman, S. J. & Crouch, M. F. The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons. Neuroscience 109, 531-536 (2002).
105. Abbott, M. A., Wells, D. G. & Fallon, J. R. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J. Neurosci. 19, 7300-7308 (1999).
106. Backman, S. Stambolic, V. & Mak, T. PTEN function in mammalian cell size regulation. Curr. Opin. Neurobiol. 12, 516-522 (2002).
107. Finger, D. C., Salama, S., Tsou, C., Harlow, E. & Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/elF4E. Genes Dev. 16, 1472-1487 (2002).
108. Pende, M. et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature 408, 994-997 (2000).
109. Guba, M. et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nature Med. 8, 128-135 (2002).
110. Huang, S. & Houghton, P. J. Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic. Curr. Opin. Investig. Drugs 3, 295-304 (2002).
111. Marx, S. O. & Marks, A. R. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 104, 852-855 (2001).
112. Magasanik, B. & Kaiser, C. A. Nitrogen regulation in Saccharomyces cerevisiae. Gene 290, 1-18 (2002).
113. Forsberg, H. & Ljungdahl, P. O. Sensors of extracellular nutrients in Saccharomyces cerevisiae. Curr. Genet. 40, 91-109 (2001).
114. Rolland, F., Winderickx, J. & Thevelein, J. M. Glucosesensing mechanisms in eukaryotic cells. Trends Biochem. Sci. 26, 310-317 (2001).
115. Olson, E. N. & Williams, R. S. Calcineurin signaling and muscle remodeling. Cell 101, 689-692 (2000).
116. Hawke, T. J. & Garry, D. J. Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534-551 (2001).
117. Kandel, E. R. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294, 1030-1038 (2001).